Sign in
4

Changes in Ownership

Avalo Therapeutics, Inc. Filed Acc 0001677036-25-000004

Options or other derivatives

  • Director acquired 40,200 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Lind Kevin Robert Director 2025-10-01 Grant or award · Stock Option (Right to Buy) +40,200 40,200 D: show line 1 in the form
Loading xslF345X05/primary_doc.xml…